Stada Launches Medical Cannabis Portfolio

Company Introduces CannabiStada Range Of Flowers And Whole Extracts

Stada has announced the launch of its medical cannabis portfolio under the brand CannabiStada in Germany. The company will be rolling out both flowers and whole extracts, primarily geared towards chronic pain patients for whom established medications, such as opioids, do not work.

medical cannabis
With the launch of CannabiStada, Stada will become one of the first companies to launch medical cannabis in the German market • Source: Shutterstock

More from Products

More from Generics Bulletin